Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma

scientific article

Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V11.I44.6920
P932PMC publication ID4717031
P698PubMed publication ID16437593
P5875ResearchGate publication ID290935300

P50authorGiacomo ZanusQ95630401
Davide Francesco D'AmicoQ117812114
P2093author name stringMario Plebani
Alessandro Vitale
Daniela Basso
Filippo Navaglia
Umberto Cillo
Vito De Pascale
Umberto Montin
Alberto Brolese
Francesco Antonio Ciarleglio
Francesco D'Amico
Marco Bassanello
P2860cites workLiver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinomaQ24540058
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the LiverQ29616866
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosisQ29619508
Prognosis of hepatocellular carcinoma: the BCLC staging classificationQ29619984
Transection of the oesophagus for bleeding oesophageal varicesQ34211834
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosisQ34515064
Prognostic prediction and treatment strategy in hepatocellular carcinoma.Q34547469
Hepatocellular carcinoma: diagnosis and treatmentQ34642891
The prognostic molecular markers in hepatocellular carcinomaQ34668320
Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?Q36474581
Is surgery for large hepatocellular carcinoma justified?Q39225087
Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.Q40525257
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective studyQ40650650
Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinomaQ40780779
Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrenceQ44391422
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patientsQ44498208
Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinomaQ44759503
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survivalQ46743120
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.Q53318354
Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.Q53350866
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancerQ62658373
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinomaQ71660134
Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassificationQ73076619
Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liverQ73107790
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgeryQ73554970
Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinomaQ73883818
Simplified staging for hepatocellular carcinomaQ77768599
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantationQ78052589
Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinomaQ78147884
Multimodal approach and its impact on survival for patients with hepatocellular carcinomaQ79357788
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?Q79363825
P433issue44
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)6920-6925
P577publication date2005-11-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleRole of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma
P478volume11

Reverse relations

cites work (P2860)
Q4613433618F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients
Q42172338A score model for predicting post-liver transplantation survival in HBV cirrhosis-related hepatocellular carcinoma recipients: a single center 5-year experience.
Q36082480Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again
Q57792485Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation
Q50851803Comparison of Salvage Living Donor Liver Transplantation and Local Regional Therapy for Recurrent Hepatocellular Carcinoma.
Q34017735Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies
Q30416480Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort
Q26772329Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation
Q64091719Role of Allelic Imbalance in Predicting Hepatocellular Carcinoma (HCC) Recurrence Risk After Liver Transplant
Q37876380Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation